Catalyst Biosciences (oral neural nicotinic receptor assets) is Buildings and Property in United States that focus on a portfolio business. They cover business area such as a portfolio, asset, oral neuronal nicotinic receptor drug, neurotransmission.
-
A Portfolio
-
260 Littlefield Avenue
San Francisco, CA 94080
United States
Private
a portfolioassetoral neuronal nicotinic receptor drugneurotransmission
* We use standard office opening hours in near Catalyst Biosciences (oral neural nicotinic receptor assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Catalyst Biosciences (oral Neural Nicotinic Receptor Assets) is Buildings and Property business from United States that founded in - ( years old in ), Catalyst Biosciences (oral neural nicotinic receptor assets) business is focusing on A Portfolio.
Catalyst Biosciences (oral neural nicotinic receptor assets) headquarter office and corporate office address is located in 260 Littlefield Avenue San Francisco, CA 94080 United States.
Catalyst Biosciences (oral neural nicotinic receptor assets) was founded in United States.
In , Catalyst Biosciences (oral neural nicotinic receptor assets) is currently focus on a portfolio sector.
Above is snippet of Google Trends for "a portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Catalyst Biosciences (oral neural nicotinic receptor assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
